ArticleThe Korean journal of internal medicine2019

Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data.

Seung Min Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.